Summary of the 5th Conference on Retroviruses and Opportunistic Infections.
Bartlett
J G
JG
D015492:AIDS Serodiagnosis; D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy / Q000821:virology; D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000627:therapeutic use; D018791:CD4 Lymphocyte Count; D004359:Drug Therapy, Combination; D005260:Female; D015658:HIV Infections / Q000517:prevention & control / Q000635:transmission; D017320:HIV Protease Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D018445:Infectious Disease Transmission, Vertical / Q000517:prevention & control; D010766:Phosphorylation; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious; D018894:Reverse Transcriptase Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use; D016879:Salvage Therapy; D013785:Thailand; D019562:Viral Load; D015215:Zidovudine / Q000008:administration & dosage / Q000378:metabolism / Q000627:therapeutic use
D019380:Anti-HIV Agents; D017320:HIV Protease Inhibitors; D018894:Reverse Transcriptase Inhibitors; D015215:Zidovudine